The effect of the IL-33/ST2 pathway on immune diseases is closely related to susceptibility to autoimmune thyroid disease and some genetic variants of IL-33/ST2 and its related neighboring genes, which provides new ideas for existing therapeutic approaches in the future. The gene discussed is IL33; the disease is autoimmune thyroid disease.